iRhythm Technologies Inc (IRTC)

Currency in USD
121.87
-2.91(-2.33%)
Closed·
121.88+0.01(+0.01%)
·
Advertisement
IRTC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
120.15125.95
52 wk Range
100.85212.00
Key Statistics
Prev. Close
121.87
Open
123.74
Day's Range
120.15-125.95
52 wk Range
100.85-212
Volume
627.27K
Average Volume (3m)
603.53K
1-Year Change
-24.9338%
Book Value / Share
5.66
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IRTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
176.86
Upside
+45.12%
Members' Sentiments
Bearish
Bullish
ProTips
7 analysts have revised their earnings downwards for the upcoming period

iRhythm Technologies Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

15 Buy
0 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 176.86
(+45.12% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Buy168.00+37.85%160.00Maintain10/08/2026
Wells Fargo
Buy168.00+37.85%180.00Maintain07/08/2026
Needham
Buy192.00+57.54%255.00Maintain07/08/2026
Stephens
Buy160.00+31.29%-New Coverage22/07/2026
Truist Securities
Buy160.00+31.29%174.00Maintain16/07/2026

iRhythm Technologies Inc Earnings Call Summary for Q2/2026

  • iRhythm Q2 revenue hit $224.2M, up 20.1% YoY, beating estimates by $4.89M; adjusted EBITDA margin reached 19.3%, up 1,000+ bps YoY.
  • Company raised FY 2026 revenue guidance to $880M-$890M and adjusted EBITDA margin outlook to 13%-14%; Q3 revenue expected at $221M-$223M.
  • Announced acquisition of VitalConnect with ~$65M annual revenue run rate; deal expected to close by end of 2026, contributing to 2027 growth.
  • Gross margin expanded to 72.8%, up 160 bps YoY, driven by manufacturing automation and scale; free cash flow reached record $37.5M.
  • Stock rose 6.4% to $132.50 after-hours; FDA warning letter and VitalConnect integration remain key risks alongside $50M litigation settlement.
Last Updated: 06/08/2026, 22:52
Read Full Transcript

Earnings

Latest Release
06/08/2026
EPS / Forecast
0.58 / -0.05
Revenue / Forecast
224.17M / 219.29M
EPS Revisions
Last 90 days

Compare IRTC to Peers and Sector

Metrics to compare
IRTC
Peers
Sector
Relationship
P/E Ratio
−288.0x−1.3x−0.4x
PEG Ratio
−3.46−0.100.00
Price/Book
21.6x2.8x2.6x
Price / LTM Sales
4.9x2.5x3.1x
Upside (Analyst Target)
42.3%26.7%47.5%
Fair Value Upside
Unlock15.0%5.9%Unlock

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.56M50.40%2.07B
Other Institutional Investors
19.98M49.60%2.49B
Public Companies & Retail Investors
0.000.00%0.00
Total
36.54M100.00%4.56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.34%2,741,505342,085
Vanguard Portfolio Management, LLC5.47%1,796,372224,151

People Also Watch

18.950
HSAI
-1.81%
247.69
CRDO
+3.23%
387.53
CIEN
-0.04%
820.59
LITE
+0.87%
311.99
ALAB
-1.65%

FAQ

What Is the iRhythm Tech (NASDAQ: IRTC) Share Price Today?

The iRhythm Tech stock price today is 121.87 USD.

What Stock Exchange Does iRhythm Tech (IRTC) Trade On?

iRhythm Tech is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for iRhythm Tech?

The stock symbol (also called a 'ticker') for iRhythm Tech is "IRTC."

What Is the Current iRhythm Tech Market Capitalisation?

As of today, iRhythm Tech (NASDAQ: IRTC) market cap is 4.02B USD.

What Is iRhythm Tech's (IRTC) Earnings Per Share (TTM)?

The iRhythm Tech EPS is currently -0.43 (Trailing Twelve Months).

When Is the Next iRhythm Tech Earnings Date?

iRhythm Tech's next earnings report will be released on 29/10/2026.

Is IRTC a Buy or Sell From a Technical Analyst Perspective?

Based on today's iRhythm Tech moving averages and other technical indicators, the daily buy/sell signal for IRTC stock is Neutral.

How Many Times Has iRhythm Tech Stock Split?

iRhythm Tech has split 0 times. (See the IRTC stock split history page for full effective split date and price information.)

How Many Employees Does iRhythm Tech Have?

iRhythm Tech has 2400 employees, based on their latest Companies House report.

What is the current trading status of iRhythm Tech (NASDAQ: IRTC)?

As of 12/08/2026, iRhythm Tech (IRTC) is trading at a share price of 121.87 USD, with a previous close of 121.87 USD. The stock has fluctuated within a day range of 120.15 USD to 125.95 USD, while its 52-week range spans from 100.85 USD to 212.00 USD.

What Is iRhythm Tech (IRTC) Price Target According to Analysts?

The average 12-month price target for iRhythm Tech is 176.86 USD, with a high estimate of 200 USD and a low estimate of 157 USD. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +45.12% Upside potential.

What Is the IRTC Premarket Price?

IRTC's last pre-market stock price is 125.59 USD. The pre-market share volume is 12,930.00, and the stock has decreased by 0.81, or 0.65%.

What Is the IRTC After Hours Price?

IRTC's last after hours stock price is 121.88 USD, the stock has decreased by 0.01, or 0.01%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.